Rehabilitation Robots Market Analysis Report 2025-2030, Featuring Profiles of Tyromotion, Hocoma, Rex Bionics, Kinova, Rehab-Robotics, ReWalk Robotics, Ekso Bionics, Cyberdyne and Bionik Laboratories [Yahoo! Finance]
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors